1 completed, 1 terminated, 1 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Pancreas Neoplasm: new trials by email Literature Review of Pancreas Neoplasm trials Research Report on Pancreas Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors NUV-868, Olaparib, Enzalutamide - Advanced Solid Tumor, Ovarian Cancer | Phase 1 | Terminated | Nuvation Bio Inc. | 82 | 2022-03-29 | 2025-11-06 |
| Preoperative Radiotherapy in Patients at High Risk of Postoperative Pancreatic Fistula After Pancreatoduodenectomy Stereotactic radiotherapy - Neuroendocrine Carcinoma of Pancreas, Duodenum Carcinoma | Phase 1 / Phase 2 | Unknown | Erasmus Medical Center | 33 | 2020-12-01 | 2022-12-07 |
| A Study of ASN007 in Patients With Advanced Solid Tumors ASN007: ascending doses, ASN007 RD - Cancer, Malignancy | Phase 1 | Completed | Asana BioSciences | 49 | 2018-01-19 | 2020-07-09 |
Pancreatic Neoplasms (3) · Breast Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Colonic Neoplasms (1) · Duodenal Neoplasms (1) · Lung Neoplasms (1) · Melanoma (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Fistula (1) · Prostatic Neoplasms (1) · Prostatic Neoplasms, Castration-Resistant (1) · Triple Negative Breast Neoplasms (1)
Digestive System Diseases (3) · Digestive System Neoplasms (3) · Endocrine Gland Neoplasms (3) · Endocrine System Diseases (3) · Neoplasms by Site (3) · Pancreatic Diseases (3) · Gastrointestinal Diseases (2) · Gastrointestinal Neoplasms (2) · Intestinal Diseases (2) · Intestinal Neoplasms (2) · Neoplasms (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Adnexal Diseases (1)
Radiosurgery (1) · enzalutamide (1) · olaparib (1)
Asana BioSciences (1) · Erasmus Medical Center (1) · Nuvation Bio Inc. (1)
United States (2) · Australia (1) · Netherlands (1)